Singapore markets close in 5 hours 41 minutes

Quoin Pharmaceuticals, Ltd. (QNRX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.7651+0.0049 (+0.64%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-8,411
-8,687
-9,381
-21,463
-2,095
Depreciation & amortisation
102.695
103.706
104.043
104.043
104.043
Stock-based compensation
1,139
1,095
764.007
0
-
Change in working capital
51.38
95.447
-94.351
632.327
274.355
Accounts payable
111.405
53.924
-217.806
1,348
227.313
Other working capital
-7,552
-7,864
-8,731
-6,345
-1,464
Other non-cash items
-
-
714.081
2,222
378.333
Net cash provided by operating activities
-7,552
-7,864
-8,481
-5,720
-1,339
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-250
-625
-125
Purchases of investments
-14,249
-18,091
-9,899
0
-
Sales/maturities of investments
15,463
20,279
0
-
-
Net cash used for investing activities
1,214
2,188
-10,149
-625
-125
Cash flows from financing activities
Debt repayment
-
0
-311.67
0
-
Other financing activities
4,800
5,217
14,319
10,029
877.485
Net cash used provided by (used for) financing activities
4,800
5,217
14,008
13,504
1,787
Net change in cash
-1,538
-459.43
-4,622
7,159
323.832
Cash at beginning of period
3,372
2,861
7,483
323.832
0
Cash at end of period
1,834
2,401
2,861
7,483
323.832
Free cash flow
Operating cash flow
-7,552
-7,864
-8,481
-5,720
-1,339
Capital expenditure
-
-
-250
-625
-125
Free cash flow
-7,552
-7,864
-8,731
-6,345
-1,464